Press Releases
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES
VANCOUVER, BC / ACCESSWIRE / May 17, 2024 / Alset Capital Inc. (TSXV:KSUM)(OTC PINK:ALSCF)(FSE:1R60, WKN:A3ESVQ) ("Alset" or the "Company") is pleased to announce that it has completed the second and final tranche (the "Second Tranche") of its non-brokered private placement of units... (continue reading...)
In completion of its fourth cycle of impact, Keep A Breast Foundation (KAB) has continued its commitment to alleviating systemic disparities in healthcare for women of color by providing 300 unrestricted grants for breast cancer survivors and patients this past cycle.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:- 300 women of color breast cancer patients and survivors received $150k in grants through Keep A Breast... (continue reading...)
Company is Poised to Participate in $4B U.S. Adult Urinary Incontinence Market
EDMOND, Okla., May 17, 2024 /PRNewswire/ -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative and accessible solutions for women's pelvic health, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Yōni.Fit® Bladder Support ("Yōni.Fit®"). Yōni.Fit® is intended for the temporary management of urine leakage caused by stress... (continue reading...)
NEW YORK--(BUSINESS WIRE)-- KBRA is assigning preliminary ratings to the Series 2024-1 Class A-2 Notes, Class B Notes, and Class C Notes (together, the Series 2024-1 Notes) from Hotwire Funding, LLC, (the Issuer), a communications infrastructure securitization.
Hotwire 2024-1 represents Hotwire Communications, Ltd.’s (Hotwire, the Company or the Parent) third securitization from its master trust, of which approximately $2.2 billion is currently outstanding,... (continue reading...)
Kelowna, British Columbia--(Newsfile Corp. - May 17, 2024) - Tryp Therapeutics, Inc. (CSE: TRYP) ("Tryp" or the "Company") announces, that it has filed amended financial statements for the six months ended February 29, 2024 (the "Financial Statements"), along with the corresponding Management Discussion & Analysis (the "MD&A"). The amendments to the financial statements resulted from a review of the financial statements conducted in May 2024 by the Company's... (continue reading...)
More Press Releases
View Older Stories-
AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.
-
Baron & Budd Attorneys Recognized by The National Law Journal 2024 Elite Trial Lawyers
-
CURO Group Holdings Corp. Announces Confirmation of Plan of Reorganization
-
Millicom (Tigo) share repurchase activity
-
Judge Appoints 'Rockstar' Lawyers to Lead Toxic Baby Food MDL
-
Tethys Petroleum Press Release: Interim Results and Corporate Update
-
May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans
-
ASPCA Condemns Dangerous Provisions in House Farm Bill That Threaten the Welfare of Millions of Animals
-
TCW to Change Listing Exchange of ETFs to NYSE
-
Xponential Fitness Provides Update on Leadership Transition
-
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Gen.video is a Two Time Silver Winner at the 2024 US Partnerships Awards for Outstanding Creative Work
-
Clairvest Partners with ECL Entertainment to Acquire Wyoming Downs
-
Visual Webmaster Redefines Presentations With "Killing PowerPoint Workshop"
-
Altius Reports Voting Results From its May 17, 2024 Annual General Meeting
-
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
-
Aion Therapeutic Completes Non-Brokered Private Placement Offering of Units
-
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Services Business
-
CLASS ACTION SETTLEMENT ANNOUNCED IN MCGRAW V. ALTUGLAS LLC PROVIDES OPPORTUNITY TO RECOVER LOSSES AFTER ACCIDENTAL RELEASE OF CHEMICALS IN DELAWARE RIVER
-
Hemlo Explorers Announces Listing on the CSE
-
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
-
Granite REIT Declares Distribution for May 2024
-
WM Technology, Inc. Announces Notification of Delinquency with Nasdaq
-
Plus Therapeutics Announces New Employment Inducement Grants
-
The Lash Group Provides Substitute Notice of Data Incident to Affected Individuals
-
How Interest Rate Comments from Powell Could Impact Clean-Energy Investment
-
Titan Provides Update on Planned Merger with Conavi
-
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
-
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
-
Statement on Chairman Glenn Thompson's 'Corrupt' House Farm Bill Released Today
-
Statement on Chairman Glenn Thompson's 'Corrupt' House Farm Bill Released Today
-
Service Properties Trust Prices an Aggregate of $1.2 Billion of Senior Unsecured Notes
-
Trump Wants to Use Crypto to Gain Edge over Biden
-
Alibaba Profit Nosedives 86% Despite Revenue Beating Estimates
-
Barclays Bank PLC Announces Change to the Coupon Ex-Date for its iPath® Select MLP ETNs
-
Dogness Announces Closing of US$5.0 Million Private Placement
-
Mars Petcare US, Inc. Voluntarily Recalls 315 Bags of PEDIGREE® Adult Complete Nutrition Grilled Steak & Vegetable Flavor Dry Dog Food, 44 lb. Bag Size
-
DWS Municipal Income Trust and DWS Strategic Municipal Income Trust Announce Annual Meeting of Shareholders
-
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment Opportunities with Airdrop Bonus
-
Now Open - Rally House Outlets at The Dells
-
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
-
CXApp Inc. (Nasdaq: CXAI) Schedules First Quarter 2024 Financial Results and Business Update Conference Call
-
Tony G Co-Investment Provides Update on Alclin Transaction
-
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
-
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
-
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024
-
Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
Big Lots to Report First Quarter Results on June 6, 2024
-
Harley-Davidson, Inc. Declares Dividend